Cancer Studies and Molecular Medicine

Open journal

ISSN 2377-1518

Systematic Review 2023 Aug

National Consensus for Screening, Diagnosis and Management of Hepatocellular Carcinoma in Panama, 2022

Moises Cukier*, José M. Cabada-Lee, Jorge D. Méndez-Ríos, Rafaél Arauz, Erik Arauz, Norberto Carreño, Ivette Clavel, Jan A. Cubilla-Rodríguez, Dafnia De Gracia, Iván Díaz, Olivia El Achtar, Kenia Franco, Julissa Lobardo-Quezada, Yong Loo, Melisa I. Menéndez, Gaspar Pérez-Jiménez, José Pinto-Llerena, Lizka Richards-Cantoral, Mauricio Rodríguez-Bravo, Maylin Ruiz, Karen E. Suñé, Ignacio Veliz and Ruth Vergara-Vásquez

Opinion 2022 Nov

Cancer Disease-Oriented-Drug Development Examples

Daniel Gandia* and Cecilia Suarez

review 2022 Nov

Anastasis: Cell Survival Mechanism

Abolaji S. Olagunju*, Folashade G. Olorunfemi, John O. Teibo and Abiodun M. Adewolu

Opinion 2022 Nov

Cancer Dynamics

Daniel Gandia* and Cecilia Suárez

Editorial 2022 Nov

Pathology Hiding in Plain Sight: The NF1 Plasma Membrane

Vincent M. Riccardi*

Opinion 2022 Nov

The Phenotype Landscape of Cancer in the Genotype Era

Daniel Gandia*

Case Series 2022 Nov

Oligo-Metastatic Carcinoma Cervix: A Few Do Extremely Well

Pallavi Nair and Francis V. James*

review 2022 Nov

Anticancer Natural Products: A Review

Ranwa A. Elrayess and Heba N. Gad El-Hak*

Original Research 2022 Nov

Deep-Ultraviolet Raman Spectroscopy for Cancer Diagnostics: A Feasibility Study with Cell Lines and Tissues

Nicole M. Ralbovsky, Vladimir Egorov, Eugene Moskovets, Paromita Dey, Bijan K. Dey and Igor K. Lednev*

Editorial 2022 Nov

Engaging African Americans in Breast Cancer Prevention Strategies: A Partnership Between a Community Cancer Center and the African American Community in Delaware

Jennifer Sims-Mourtada*, Zohra Ali-Khan Catts, Patricia Swanson and Nora Katurakes

Systematic Review 2022 Nov

The Emerging Spectrum of Early Life Exposure-Related Inflammation and Epigenetic Therapy

Qiwei Yang*, Mohamed Ali, Abdeljabar El Andaloussi, Ayman Al-Hendy

Illustration 2022 Nov

A Case of Choroidal Metastasis from Small-Cell Lung Carcinoma

Manami Inoue, Takeshi Saraya*, Miku Oda, Masachika Fujiwara and Hajime Takizawa

Illustration 2022 Nov

Bilateral Symmetric Thalamic Metastasis in a Patient with Small Cell Lung Cancer

Takeshi Saraya*, Chie Shimura, Sayuki Inaoka and Hajime Takizawa

Editorial 2022 Nov

The Emerging Role of p27 in Development of Diseases

Qiwei Yang* and Ayman Al-Hendy

Case Report 2022 Nov

A Rare Case of a Urachal Mucinous Cystic Tumour of Low Malignant Potential

Kanchan K. Palial*, Bob Yang, Philip J. S. Charlesworth, Charles E. Lewis, Lisa Browning and Clare Verrill

Case Study 2022 Nov

Dosimetric Characterization of an Abscopal Response in a Patient With Oligometastatic Melanoma Undergoing Concurrent Treatment With Pembrolizumab and Stereotactic Body Radiotherapy (SBRT)

Jennifer Sims-Mourtada*, Serguei Casteneda, David Huang, John McGlade, Sunjay Shah, Lindsay Romak, Adam Raben and Firas Mourtada

Original Research 2022 Nov

Classifying Lung Adenocarcinoma and Squamous Cell Carcinoma using RNA-Seq Data

Zhengyan Huang, Li Chen and Chi Wang*

Editorial 2022 Nov

Dysadherin: A Novel Oncogenic Molecular Biomarker in Oesophageal Cancer

Alexandros Charalabopoulos* and Theodoros Liakakos

Mini Review 2022 Nov

How Target Therapy can Induce Cardiotoxicity: The Onco-Cardiologist Point of View

Joana Espiga de Macedo*

Letter to the Editor 2022 Nov

Is it Time to Start Using Mitochondrial DNA Copy Number as an Indicator of Health and Diseases?

Vasudeva G. Kamath*

Original Research 2022 Nov

Neurofibromatosis Type I and Multiple Gastrointestinal Stromal Tumors: A Unique Identity

Joana Espiga de Macedo*

Editorial 2022 Nov

Potential of Molecular Imaging to Advance Molecular Medicine

Pradeep K. Garg*

Original Research 2022 Nov

Rounding Down Chemotherapeutic Agents to the Nearest Vial Size as a Cost Containment Measure

Yousef Al-Olah, Nasser Mahdi Al-Qhtani*, Maj Mohammed A. Al Waheeby, Abdul-Rahman I. Al-Ghamdi, Ghadah Al Yousif, Al Hanouf N. Al Dajani, Nourah M. Al Henaki and Ahlam M. Al Zahrani

Editorial 2022 Nov

Prostate Cancer Trends in Developing Countries

Aleyamma Mathew and Francis V. James*

Observational Study 2022 Nov

Gastrointestinal Stromal Tumors: Innovation from Diagnosis to Treatment Based on 15 Years of Experience of a Peripheral Hospital in Portugal

Joana Espiga de Macedo*, Sílvia Lopes, Mónica Pinho and Pedro Santos

Original Research 2022 Nov

Current Status of Anti Epidermal Growth Factor Receptor Therapy in the Curative Treatment of Head and Neck Squamous Cell Carcinoma

Cessal Thommachan Kainickal*, Aparna M. P., Rejnish Kumar Ravi Kumar, Malu Rafi and Kunnambath Ramadas

Original Research 2022 Nov

The Proportion of ALDEFLUOR-Positive Cancer Stem Cells Changes with Cell Culture Density Due to the Expression of Different ALDH Isoforms

Lynn M. Opdenaker, Shirin R. Modarai and Bruce M. Boman*

Brief Research Report 2022 Nov

Activation of Inflammatory Responses Correlate With Hedgehog Activation and Precede Expansion of Cancer Stem-Like Cells in an Animal Model of Residual Triple Negative Breast Cancer after Neoadjuvant Chemotherapy

Kimberly M. Arnold, Nicole J. Flynn and Jennifer Sims-Mourtada*

Mini Review 2022 Nov

Treatment of Stage I Seminoma

Milan Anjanappa, Cessal Thommachan Kainickal and Francis V. James*

Editorial 2022 Nov

Boosting Response: The Impact of Immune Checkpoint Inhibitors on Radiation Treatment Schedules

Firas Mourtada and Jennifer Sims-Mourtada*

Case Report 2022 Nov

Skin Hypopigmentation in a Patient with Papillary Carcinoma Thyroid Treated with Sorafenib

Athira Raju, Mathews Jose, Arun Philip and Keechilat Pavithran*

Opinion 2022 Nov

Knowledge of the Molecular Signaling Pathways Improves the Chances of Treatment of Gastrointestinal Stromal Tumors

Joana Espiga de Macedo*

Letter to the Editor 2022 Nov

Immuno-oncology: Is it a new hope for cancer patients?

Anoop Kumar*

Short Communication 2022 Nov

Long Term, Low Dose Genistein decreases Stem Cell Populations and Sensitizes Inflammatory Breast Cancer Cell Lines to Radiation

Jennifer Sims-Mourtada*, Lynn M. Opdenaker, Joshua Davis and Changqing Wu

Original Research 2022 Nov

MAPK/ERK Activation Sensitizes MKN-28 Cells to Cisplatin-Induced Apoptosis

Zhan-Guo Zhang, Yan-Hui Wu, Hui-Fang Liang, Bi-Xiang Zhang and Wan-Guang Zhang*

review 2022 Nov

Flavones and Flavonols may have Clinical Potential as CK2 Inhibitors in Cancer Therapy

Mark F. McCarty*

review 2022 Nov

Elimination of Tumor Suppressor Proteins during Liver Carcinogenesis

Nikolai A. Timchenko* and Kyle Lewis

Original Research 2022 Nov

Effects of Three Dimensional Microenvironment on Tumorigenicity of Fibrosarcoma in vitro

Irit Levinger, Racheli Zagouri, Yvonne Ventura and Razi Vago*

Editorial 2022 Nov

Role of Molecular Imaging in Oncology

Pradeep K. Garg*, Surinder K. Batra and Sudha Garg

review 2022 Nov

Application of Radionuclides and Antibody -Drug Conjugates to Target Cancer

Sean L. Kitson*

Mini Review 2022 Nov

Regulation in Cell Cycle via p53 and PTEN Tumor Suppressors

Yasuko Kitagishi*, Satoru Matsuda*, Akari Minami, Yuna Ono, Atsuko Nakanishi and Yasunori Ogura

ARCHIVE

Volume 1
- Volume 1 – Issue 1

-

Arabic

-

ar

Bengali

-

bn

German

-

de

English

-

en

French

-

fr

Hindi

-

hi

Indonesian

-

id

Portuguese

-

pt

Russian

-

ru

Spanish

-

es